Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 1999

View Archived Issues

Transplanted neural stem cells compensate for missing cell types

NAVA's novel meningococcal vaccine elicits immunologic memory

More data presented on Immunomedics' infection diagnostic at medical conference

NeoRx's Pretarget technology permits higher doses of radiation in lymphoma patients

Aviron completes FluMist bridging study

Seven preclinical studies demonstrate antitumor activity of NovoMAb-G2

B7-2/GM-CSF immunogene therapy: a novel approach to the treatment of glioma

Canadian study supports efficacy of Cerebrolysin in patients with mild AD

Kos to copromote two cardiovascular drugs with Knoll

Ortec to initiate pivotal study of Composite Cultured Skin

Cerep and Tibotec initiate HIV drug discovery collaboration

Tacrine may reduce symptoms of Tourette syndrome

Regeneron meets strategic objectives in 1998

MORE trial results: raloxifene prevents breast cancer in postmenopausal women

Vinylamycin: new antibiotic discovered by Japanese research group

Schering-Plough prepares potent H3 antagonists for allergy, CNS disorders, etc.

CPMP recommends approval of DMARD

New Egis compounds lower blood pressure without marked increases in heart rate

Isoprinosine as a potential treatment for chronic fatigue syndrome

Effects on sexual function in hypertensive males: not all antihypertensives are created equal

Pharmacia & Upjohn claims new antibacterial oxazolidinones

Sankyo's olmesartan featured at European meeting

Glutamate release inhibitors, their preparation and use disclosed by Novartis

St. Elizabeth's discovers new N-acetylserotonin derivatives useful for hypertension, depression

Suntory compounds exert both lipid peroxidation- and Ca2+ overload-suppressing effects

Pharmacia & Upjohn seeks merger with Sugen

Potent and orally active human renin inhibitor selected for further study at Roche

Leukotriene antagonist effective and well tolerated as migraine prophylaxis

FDA grants orphan drug designation to PPL's AAT for congenital deficiency

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...